Press releases

2020  |  2019  |  2018  |  All
January 6, 2020
Compass Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 2, 2019
Compass Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference
October 24, 2019
Compass Therapeutics to Present Preclinical Data on a Novel PD-1/PD-L1 Bispecific Antibody and from its Proprietary Innate Cell Engager Platform at the 2019 SITC Meeting

Presentations and publications

View all
November 12, 2019 | SITC 2019
CTX-8371, a Novel Bispecific Targeting both PD-1 and PD-L1, is more Potent than Combination anti-PD-1 and PD-L1 Therapy and Provides Enhanced Protection from Tumors in vivo
November 12, 2019 | SITC 2019
A novel class of Innate Cell Engagers targeting NKp30
April 10, 2019 | Keystone Symposia Conference: “D2: Antibodies as Drugs: New Horizons in the Therapeutic Use of Engineered Antibodies”
Novel class of NK engagers targeting NKp30 selected from unbiased screen of common light chain based bispecific antibodies

In the news

View all
December 11, 2019
Nature Reviews Drug Discovery: Immune agonist antibodies face critical test
December 4, 2019
BioWorld -Two’s companies: Crowd in bispecifics still growing as methodology sorted
October 2, 2018
FierceBiotech’s 2018 Fierce 15

Events

Keystone -Advances in Cancer Immunotherapy
March 22 – 26
Whistler, British Columbia
AACR Annual Meeting
April 24 – 29
San Diego, California
16th Annual PEGS Boston
May 4 – 8
Boston, Massachusetts
ASCO Annual Meeting
May 29 – June 2
Chicago, Illinois